JTCVS Open (Jun 2024)

Value of nutritional indices in predicting survival free from pump replacement and driveline infections in centrifugal left ventricular assist devicesCentral MessagePerspective

  • Fabian Jimenez Contreras, MD,
  • Bret L. Pinsker, MD,
  • Jason N. Katz, MD, MHS,
  • Stuart D. Russell, MD,
  • Jacob Schroder, MD,
  • Benjamin Bryner, MD,
  • Alexander H. Gunn, MD,
  • Krunal Amin, MD,
  • Carmelo Milano, MD

Journal volume & issue
Vol. 19
pp. 175 – 182

Abstract

Read online

Objective: There is a paucity of data assessing the impact of nutritional status on outcomes in patients supported with the HeartMate 3 (HM3) left ventricular assist device (LVAD). Methods: Patients ≥18 years of age who underwent HM3 LVAD implantation between 2015 and 2020 were identified from a single tertiary care center. The primary outcome assessed was death or device replacement. A secondary outcome of driveline infection was also evaluated. Kaplan-Meier survival analysis and a multivariate Cox-proportional hazards model were used to identify predictors of outcome. Results: Of the 289 patients identified, 94 (33%) experienced a primary outcome and 96 (33%) a secondary outcome during a median follow-up time of 2.3 years. Independent predictors of the primary outcome included peripheral vascular disease (hazard ratio [HR], 3.40; 95% confidence interval [CI], 1.66-6.97, P 33, may be of value in this population.

Keywords